The Impact of the Gut Microbiota on the Pathogenesis and Management of Insulin Resistance

Insulin resistance is a pathophysiological state, defined as a diminished biological response to insulin stimulation of target tissues, primarily the liver, muscles and adipose tissue. It has been identified as a significant factor in the development of certain diseases including type II diabetes mellitus, metabolic syndrome and obesity, and is concurrently associated with an elevated risk of cardiovascular disease and several cancers. A substantial amount of research has indicated a correlation between the occurrence of insulin resistance and imbalances in gut microbiota diversity. Intestinal dysbiosis has been demonstrated to contribute to a reduction in the synthesis of beneficial bacterial metabolites and to an increase in the production of pro-inflammatory cytokines and intestinal barrier permeability, allowing lipopolysaccharide to enter the bloodstream. These mechanisms have been shown to promote the development of inflammation and, consequently, insulin resistance. Therefore, a more profound comprehension of these processes is a matter of significance, as it may potentially facilitate the establishment of more specific and efficacious methods for the prevention and treatment of metabolic diseases.